| Chanderbhan Psychological Services Pllc Susan Chanderbhan-forde | |
|
5219 Mcpherson Rd Ste 312 Laredo TX 78041-7322 | |
| (956) 898-1595 | |
| Not Available |
| Full Name | Chanderbhan Psychological Services Pllc Susan Chanderbhan-forde |
|---|---|
| Speciality | Psychologist |
| Location | 5219 Mcpherson Rd Ste 312, Laredo, Texas |
| Authorized Official Name and Position | Susan Chanderbhan-forde (CEO / LICENSED PSYCHOLOGIST) |
| Authorized Official Contact | 9568981595 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Chanderbhan Psychological Services Pllc Susan Chanderbhan-forde 5219 Mcpherson Rd Ste 312 Laredo TX 78041-7322 Ph: (956) 898-1595 | Chanderbhan Psychological Services Pllc Susan Chanderbhan-forde 5219 Mcpherson Rd Ste 312 Laredo TX 78041-7322 Ph: (956) 898-1595 |
| NPI Number | 1073959821 |
|---|---|
| Provider Enumeration Date | 05/21/2013 |
| Last Update Date | 03/07/2023 |
| Certification Date | 03/07/2023 |
| Medicare PECOS PAC ID | 6901228873 |
|---|---|
| Medicare Enrollment ID | O20200623000459 |
News Archive
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.
CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012.
Testicular cancer is the most common cancer among men under 40 in Europe and the USA. National statistics from the Cancer League indicate 471 new cases and 12 deaths in Switzerland.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073959821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 36142 (Texas) | Primary |
| Provider Name | Susan Chanderbhan-forde |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1982946935 PECOS PAC ID: 0244474088 Enrollment ID: I20130918000460 |
News Archive
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.
CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012.
Testicular cancer is the most common cancer among men under 40 in Europe and the USA. National statistics from the Cancer League indicate 471 new cases and 12 deaths in Switzerland.
› Verified 7 days ago
News Archive
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.
CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012.
Testicular cancer is the most common cancer among men under 40 in Europe and the USA. National statistics from the Cancer League indicate 471 new cases and 12 deaths in Switzerland.
› Verified 7 days ago
Buena Salud Day Treatment Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5415 Springfield Ave, 2b, Laredo, TX 78041 Phone: 956-722-7381 | |
Guillermo E Gonzalez Jr Phd Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6826 Springfield Ave, Suite 103a, Laredo, TX 78041 Phone: 956-722-3000 | |
Vasquez Counseling & Consulting Psychology Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6826 Springfield Ave, Suite 103a, Laredo, TX 78041 Phone: 956-319-7914 Fax: 956-729-1947 | |
Motion Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6548 Springfield Ave Num 202, Laredo, TX 78041 Phone: 956-267-9141 Fax: 956-290-8297 | |
Dm Casemanagement Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1115 Chihuahua, Suite C, Laredo, TX 78043 Phone: 956-635-7747 | |
Courageous Counseling Center, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6510 Polaris Dr Ste 2, Laredo, TX 78041 Phone: 956-707-3076 |